Key Takeaways
- Fluence Energy slashed its fiscal 2026 revenue forecast to $2.4 billion from $3.0 billion, representing a $600 million reduction
- Manufacturing issues at the Houston facility proved catastrophic, with daily production falling to just one unit versus the projected eleven
- Baird issued an Underperform rating with a $3.00 price target; Canaccord reduced its target to $15.00 while maintaining a Buy stance
- The company’s adjusted EBITDA outlook deteriorated to a $200 million loss from a previously expected $10 million loss
- Shares currently trade at $9.05, reflecting a 54% decline year-to-date, with Wall Street forecasting continued losses
Shares of Fluence Energy have plummeted to $9.05, marking a devastating 54% drop year-to-date, following the company’s announcement of dramatically reduced fiscal 2026 projections stemming from severe operational challenges at its Houston manufacturing site.
The energy storage company’s revised fiscal 2026 revenue projection now stands at roughly $2.4 billion, a significant pullback from the previously communicated $3.0 billion target. This $600 million deficit traces back primarily to persistent difficulties at a single critical facility: the Houston production plant.
The Houston facility alone accounts for $450 million of the total revenue shortfall. During what should have been a successful late summer production ramp, the plant was anticipated to deliver eleven units daily. Reality proved far grimmer, with output bottoming at a single unit per day.
CEO Julian Nebreda acknowledged the company had significantly miscalculated the operational challenges inherent in the Houston plant’s ramp-up. Automated welding infrastructure experienced complete failures, necessitating an emergency pivot to manual processes. A shortage of qualified workers in final assembly operations compounded the crisis until the company secured three regional subcontractors to bridge the gap.
While corrective actions eventually lifted production to three units daily, the financial consequences were already locked in.
The aggregate financial impact reached $190 million. This figure encompasses $130 million from contractual penalties combined with revenue recognition delays extending into fiscal 2027, alongside $60 million absorbed through deployment complications and quality compliance expenses.
Financial Outlook Deteriorates
The company’s adjusted EBITDA projection for fiscal 2026 now anticipates a loss of roughly $200 million, a dramatic worsening from the previous midpoint estimate of a $10 million loss. Approximately two-thirds of this incremental loss stems directly from unmet project delivery commitments.
With gross profit margins compressed to just 9.36%, the operational strain is unmistakable. Three analysts have recently lowered their earnings forecasts for the coming period, and consensus projections indicate the company will remain unprofitable throughout the current fiscal year.
During a recent investor call, Fluence disclosed plans to temporarily scale back its U.S. operationsāa strategic retreat that Baird characterized as significantly concerning.
Analyst Community Responds
Baird issued a downgrade to Underperform from Neutral while dramatically reducing its price target to $3.00 from $10.00. The firm emphasized the revised guidance and U.S. market withdrawal as primary concerns, noting the implied nearly 50% sequential decline projected for the fourth quarter.
Canaccord adopted a contrarian position, lowering its price target to $15.00 from $24.00 while retaining a Buy rating, contending that shares appear significantly undervalued at present levels.
BMO Capital reduced its target to $7.00 while maintaining a Market Perform stance. Morgan Stanley adjusted its target downward to $15.00 from $16.00, keeping an Equalweight rating and aligning its financial models with the updated company guidance.
In a notable reversal, UBS upgraded FLNC to Neutral from Sell. Analyst Jon Windham posited that the guidance reduction could represent a trough for near-term earnings expectations, with meaningful growth potential materializing in fiscal 2027.
GLJ Research moved to Hold from Buy, expressing skepticism about the company’s ability to successfully monetize its substantial $6.4 billion contracted backlog.
Fluence currently maintains $1.0 billion in advance customer payments. The stock declined an additional 2.69% in recent trading to close at $9.05.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
